With a rare network of partnerships and relationships in China, Cinpathogen offers:

• Powerful, multi-disciplinary research capabilities
• The exceptional advantage that comes from research conducted in a single laboratory
• The high case accrual that China is known for

Shanghai hospital network
Cinpathogen has well established clinical and research relationships with over 30 hospitals in Shanghai, which has allowed company scientists and physicians to diagnose, collect and characterize over 3000 cases of hematopoietic and lymphoid disease over the past five years. 

Fudan-Cinpathogen Center for Clinical and Molecular Research in the Institutes of Biomedical Sciences at Fudan University 
Cinpathogen is a major partner in the Fudan-Cinpathogen Center for Clinical and Molecular Research (CMRC) in the Institutes of Biomedical Sciences at Fudan University in Shanghai. 

The Fudan-Cinpathogen CMRC is one of the most extensive laboratories in China dedicated to oncology research on the blood and immune system.

In support of the Institute’s biomedical research goals,  the CMRC focuses on the etiology and pathogenesis of disease and conducting clinical studies to predict individual response and follow up to treatment. 

CMRC staff provide sample collection and storage for cryopreserved PBMC, tumor cells, DNA, RNA and tissue. Samples are linked with individual study subject diagnosis and molecular data via a computerized audit-tracking system, which facilitates management of clinical and molecular studies while preserving individual subject confidentiality.